AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Ovarian ca risk linked to some HRT regimens. (Do not Alter Prescribing).

OB GYN News

| July 15, 2002 | Rudd, Terry | COPYRIGHT 2002 International Medical News Group. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

Hormone replacement therapies using estrogen alone or in combination with sequential progestin supplementation may put women at significantly increased risk of epithelial ovarian cancer, reported Dr. Tomas Riman of Falu Hospital, Falun, Sweden, and his associates.

Despite these findings, the investigators did not recommend that clinicians change current HRT prescribing practices. Any decision regarding HRT use must address the therapy's impact on coronary artery disease, osteoporosis, venous thrombosis, and other health effects, the researchers said (J. Natl. Cancer Inst. 94[71:497-504, 2002).

The study included 655 women between 50 and 74 years old with newly diagnosed epithelial ovarian cancer and a control group of 3,899 women. HRT use was divided into four categories: unopposed estrogen, estrogens combined sequentially with progestin, estrogens combined continuously with progestins, ...

Related articles from newspapers, magazines, journals, and more
Researchers develop first mouse model.(of epithelial ovarian cancer)
Newspaper article from: Cancer Weekly April 8, 2003 700+ words
...human ovarian cancer - epithelial ovarian cancer. The mouse model provides...her colleagues develop epithelial ovarian cancer in both ovaries. This...transgenic animals that develop epithelial ovarian cancer that spreads to the peritoneal...
Researchers develop first mouse model.(for epithelial ovarian cancer)
Magazine article from: Women's Health Weekly April 10, 2003 700+ words
...human ovarian cancer - epithelial ovarian cancer. The mouse model provides...her colleagues develop epithelial ovarian cancer in both ovaries. This...transgenic animals that develop epithelial ovarian cancer that spreads to the peritoneal...
Failure to Demonstrate Human Papillomavirus DNA in Epithelial Ovarian Cancer by.
Magazine article from: OB/GYN Clinical Alert June 1, 1999 700+ words
...Papillomavirus DNA in Epithelial Ovarian Cancer by General Primer PCR...randomly selected 98 cases of epithelial ovarian cancer from a series of 445 patients...in the development of epithelial ovarian cancer. Comment by Kenneth Noller...
Initial chemotherapy beneficial in epithelial ovarian cancer.(News)
Magazine article from: OB GYN News Lowry, Fran March 1, 2006 700+ words
...patients with advanced epithelial ovarian cancer, a retrospective comparative...Most women with advanced epithelial ovarian cancer receive initial surgery...was 85% in 98 advanced epithelial ovarian cancer patients who received...
Gemcitabine yields favorable results vs. recurrent epithelial ovarian cancer.
Newspaper article from: Cancer Weekly June 29, 2004 700+ words
...patients with recurrent epithelial ovarian cancer and yielded clinical benefit...treatment of recurrent epithelial ovarian cancer." Given the 5-year...for women with advanced epithelial ovarian cancer, Inbar and associates...
Hormone Replacement Therapy Formulations and Risk of Epithelial Ovarian Cancer.
Newspaper article from: Clinical Oncology Alert November 1, 2002 700+ words
...Formulations and Risk of Epithelial Ovarian Cancer Abstract & Commentary...and the risk of invasive epithelial ovarian cancer in women participating...between any use of HRT and epithelial ovarian cancer. Although use of unopposed...
Algorithm predicts epithelial ovarian cancer risk.(WOMEN'S HEALTH)
Magazine article from: Family Practice News MacNeil, Jane Salodof April 1, 2009 700+ words
...at high or low risk for epithelial ovarian cancer based on menopausal stares...classified 94% of women with epithelial ovarian cancer in a prospective, double...disease and all stages of epithelial ovarian cancer determined ROMA's sensitivity...
Pegylated Liposomal Doxorubicin vs. Topotecan for Recurrent Epithelial Ovarian...
Magazine article from: OB/GYN Clinical Alert October 1, 2001 700+ words
...Topotecan for Recurrent Epithelial Ovarian Cancer Abstract & Commentary...patients with recurrent epithelial ovarian cancer that recurred after or...MD Once patients with epithelial ovarian cancer relapse, their curability...
For more facts and information, see all results

Source: HighBeam Research, Ovarian ca risk linked to some HRT regimens. (Do not Alter...

©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA